Immunoprotective Effect of Liver Allograft on Patients with Combined Liver and Kidney Transplantation

06 February 2024 : Original article

Joon-Young Kim

^1BCDEF, Hye Bin Kim^2BCDEF, Jin-Myung Kim

^1BCD, Hye Eun Kwon

^1BCD, Young Hoon Kim

^1BCD, Youngmin Ko

^1BCD, Frances S. Sung

^1BCD, Joo Hee Jung

^1BC, Chung Hee Baek

^3B, Hyosang Kim

^3B, Su-Kil Park

^3B, Sung Shin

^1BCD, Hyunwook Kwon^1ABCDEF*

DOI: 10.12659/AOT.942763

Ann Transplant 2024; 29:e942763

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Supplementary Table 1 Comparative analysis of rejection types and incidences.

	KTA (n=4268)	LTKT (n=44)	P-value
1-year rejection	384 (9.0%)	2 (4.5%)	0.43
Overall rejection	973 (22.8%)	3 (6.8%)	0.012
ACR only	380 (8.9%)	2 (4.5%)	0.49
AMR only	77 (1.8%)	0 (0%)
ACR+AMR	510 (11.9)	3 (6.8%)
ACR – acute cellular rejection; AMR – acute antibody-mediated rejection.

Back to the Article